Matthew Burke on Potential Challenges Facing Nurses in the Field of Immunotherapy

August 25, 2014
Matthew Burke, MBA, RN, MSN, APRN-BC

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses potential challenges nurses might face with the new advent on immunotherapy.

Matthew Burke, MBA, RN, MSN, APRN-BC, Oncology Nurse Practitioner/Melanoma and Renal Cell Carcinoma, Yale New Haven Hospital, discusses potential challenges nurses might face with the new advent on immunotherapy.

Burke says immunotherapy is the beginning of a new paradigm in the treatment of cancer. In addition to learning about side effects associated with these agents, nurses are going to understand how to deal with combinations of immunotherapy agents.

Nurses will also be challenged to learn more about sequencing therapy, Burke says, which brings in a whole new class, and possible severity, of toxicity.